APA (7th ed.) Citation

Srikantiah, P., & Klugman, K. P. (2023). New respiratory syncytial virus immunization products in low- and middle-income countries: Potential for cost-effective impact on a high burden of disease in young infants. BMC medicine, 21(1), 177-3. https://doi.org/10.1186/s12916-023-02883-x

Chicago Style (17th ed.) Citation

Srikantiah, Padmini, and Keith P. Klugman. "New Respiratory Syncytial Virus Immunization Products in Low- and Middle-income Countries: Potential for Cost-effective Impact on a High Burden of Disease in Young Infants." BMC Medicine 21, no. 1 (2023): 177-3. https://doi.org/10.1186/s12916-023-02883-x.

MLA (9th ed.) Citation

Srikantiah, Padmini, and Keith P. Klugman. "New Respiratory Syncytial Virus Immunization Products in Low- and Middle-income Countries: Potential for Cost-effective Impact on a High Burden of Disease in Young Infants." BMC Medicine, vol. 21, no. 1, 2023, pp. 177-3, https://doi.org/10.1186/s12916-023-02883-x.